Pharmaceutical & healthcare

Download examples of our expertise in this sector.

Enter your email in the box below to download our latest engagement example.

Capital asset valuation, management and used equipment sales for the pharmaceutical and healthcare sector

Reduce risk, improve asset performance and increase return on investment

pharma

For pharmaceutical and healthcare companies needing to manage:

  • The unprecedented demand for affordable drugs and healthcare
  • The effects of global population growth
  • Diseases and health concerns in both the developing and developed world

A comprehensive range of sector specific services including:

Pharmaceutical sector capital assets

Take into account that pharmaceutical assets are:

  • Highly technical and specialised, often incorporating intellectual property
  • Complex assets with polarised residual market values
  • Material balance sheet assets

Healthcare sector capital assets

A significant number and value of assets, from laboratory estate to clinical equipment

  • Global markets with predictable residual values
  • Utilised by public and private sector organisations

Why sector expertise matters in the pharmaceutical and healthcare sector

Hickman Shearer’s experts understand the capital asset challenges associated with:

  • Stringent contamination regulations
  • Significant R&D cost management
  • A complex global production supply chain
  • Retaining accurate fixed asset records and information
  • Using book values to benchmark transactions

Asset valuation reports provide

  • Sector relevant expert advice
  • RICS regulated valuations
  • Evidence based market analysis
  • Relevant and robust recommendations and advice

Asset management services provide

  • Physical verification and electronic reconciliation of assets and systems
  • Asset tagging
  • Financial and operational asset integration systems
  • End-of-life asset strategies

Equipment sales services provide

  • Pre-sale valuation
  • Global marketing and advertising
  • On-line auctions and negotiated sales
  • RICS compliant accounting and reporting

So that those in the pharmaceutical and healthcare sector can:

  • Utilise valuations to respond to and resolve M&A, debt, financial, regulatory, tax, insurance and compulsory purchase issues
  • Improve asset performance and return on asset investment through improved asset management
  • Maximise the realisation of surplus or end-of-life assets

Your quality guarantee

Whatever your pharmaceutical and healthcare asset valuation or asset management requirement, you can be assured that Hickman Shearer’s work is clear, unambiguous and is conducted under RICS and other industry standard bases of value.

Have a question? Contact us and speak to our asset valuation, asset management and equipment sales experts to answer any questions you may have.

Get in touch

Need a plant, machinery or equipment valuation estimate right now?

Schedule a consultation 

Need asset management services?

Schedule a consultation

Need advice about asset sales?

Schedule a consultation

Join the list of pharmaceutical and healthcare clients that we have successfully assisted:

Cherwell Laboratories, GlaxoSmithKline, Novartis, Organon, Pfizer, Sara Lee, Sogefi Aventis, Whatman 

Relevant experience 1

Increased capital allowances for global pharmaceutical manufacturer

Relevant experience 2

Ongoing insurance reinstatement costs for a global pharmaceutical manufacturer

These engagements were performed by the Directors of Hickman Shearer in either their current or previous employment